Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
36 participants
INTERVENTIONAL
2016-03-31
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
However, the cardiorespiratory synchronization in the MRI, allowing acquisition of synchronous images with breathing and heart movements should increase the sensitivity of detection of pathologic mediastinal lymph nodes.
Given its high sensitivity, whole-body MRI with diffusion could possibly be at least as informative as PET, while being less expensive, not radiant.
The purpose of this study is to evaluate the performance of whole-body MRI with diffusion with cardiorespiratory synchronization, on the detection of mediastinal nodes (which are known to be less well detected by MRI) compared to PET.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detection and Characterization of Residual Masses in Lymphomas
NCT02300402
Imaging Multiparametric/Multimodality for Lungcancer
NCT02977663
MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma
NCT02733887
PET/CT-Based Image Analysis and Machine Learning of Hypermetabolic Pulmonary Lesions
NCT06602674
MRI Optimization Study in Stage III NSCLC
NCT02076282
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MRI
Wholebody MRI with cardio-pulmonary synchronization At day 1 , at the afternoon, patient will undergo an MRI analysis.
MRI
Whole body MRI with cardiac and pulmonary synchronization
PET
At day 1 , in the morning, patient will undergo an PET analysis
PET
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI
Whole body MRI with cardiac and pulmonary synchronization
PET
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Neoplasia bronchopulmonary (SCLC and NSCLC) newly diagnosed,
* Patient potentially eligible for curative treatment, but no no treatment started,
* Patients for whom a PET scan and MRI are planned
* claustrophobia,
* Implantable Medical Device
* not compatible pacemaker type or heart valve, metal splinters eye)
* Pregnant or lactating women,
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Limoges
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Limoges
Limoges, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
I15037/WILSON
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.